PD-1/PD-L1 signaling is critical to enhanced tumor progression, metastasis, and drug resistance and acts as a crucial component of tumor immunosuppression; this includes inhibiting T lymphocyte activation and enhancing tumor cell immune tolerance, leading to tumor cell immune escape (19, 43). This evidence concerns the gene CD274 and neoplasm.